--- title: "China's \"BeiNao-1 (北脑一号)\" just cleared 10 human implants — what a semi-invasive brain chip actually changes" date: 2026-09-27 category: Brain–Computer Interface site: NeuroAI canonical: https://neuroai.site/a/na-bci-beinao-10-implants language: en --- # China's "BeiNao-1 (北脑一号)" just cleared 10 human implants — what a semi-invasive brain chip actually changes > A Beijing-backed brain-computer interface has reached 10 implants with over 45,000 hours of safe operation. We explain the extradural approach, what patients regained, and why "semi-invasive" matters for real-world medicine. A man who lost the use of all four limbs in a fall can now move a robotic arm with his thoughts. A woman paralyzed from the chest down for five years stood and walked with a walker after a surgery that never entered her brain tissue. These are not demo clips from a lab Open House — they are early clinical results from **BeiNao-1 (北脑一号)**, a Chinese brain-computer interface (BCI) that just crossed a quiet but important line: more than ten people are now living with it implanted. For anyone watching the field, the interesting part is not the headline number. It is *how* the device gets inside the skull, and what that choice says about where China thinks BCI medicine is actually going. ## The implant that stays outside the brain Most people picture BCI as a chip pushed deep into brain tissue — the path Neuralink made famous. BeiNao-1 (北脑一号) takes the opposite route. It is **semi-invasive (半侵入式)**, placed **extradurally (硬膜外)** — above the dura mater, the protective layer wrapping the brain, through a small cranial window. It does not pierce the tissue itself. That sounds like a compromise. In medicine, it is often the opposite. Penetrating electrodes capture sharper signals but carry higher risk of scarring, inflammation and long-term tissue damage. An extradural device trades a little signal sharpness for a much larger safety margin — which is exactly what you want when the "patient" is someone who has to live with the implant for years, not minutes. The system runs **128 channels** and, according to the Beijing Institute for Brain Science and Brain-Inspired Research, has kept **over 98% of its channels functional** after implantation, with the longest case now past one year. ## What patients actually got back The results, disclosed by the institute and reported by state media in April 2026, are specific enough to matter: - A patient with cervical spinal-cord injury, paralyzed for over a year, regained control of a robotic arm, a muscle-stimulation device and a computer cursor — and showed gradual recovery in arm strength scores. - A patient paralyzed in both legs for five years, after implantation, trained with a lower-limb exoskeleton and regained the ability to stand and walk with underarm crutches, and recovered voluntary bladder and bowel control. - People who had lost speech decoded roughly a hundred common Chinese words from neural signals. The first formal **GCP (Good Clinical Practice)** multicenter trial implant was performed on April 2, 2026 at Xuanwu Hospital in Beijing, with an initial cohort of 36 patients planned. By mid-April, ten implants were in place with **more than 45,000 hours of cumulative safe operation**. ## Who built it, and why it is state-backed BeiNao-1 (北脑一号) was developed by **NeuCyber (Beijing Xinzhida Neurotechnology, 芯智达)**, working with the Beijing Institute for Brain Science and Brain-Inspired Research. Luo Minmin (罗敏敏), the institute's director, is also the company's founder. The effort is backed by the Beijing municipal government and the Zhongguancun Development Group — a structure that treats BCI less as a startup bet and more as public-health infrastructure. That framing shows up in the tech roadmap. A fully **invasive (侵入式)** follow-on, **BeiNao-2 (北脑二号)**, is a 512-channel wireless fully-implanted prototype now in large-animal testing, with clinical validation targeted within 2026. Running both paths at once is unusual; most companies pick one. China is also pushing on standards: an ISO specification, *Information Technology — Brain-Computer Interfaces — Vocabulary*, led by Chinese experts and published in April 2026, is the field's first unified terminology framework. ## Why this matters beyond China Researchers here are candid that China started the invasive-BCI race roughly 10–15 years behind the United States and still trails in depth of talent. What changed is speed: a focused national push turned a research milestone into implanted, working patients in a few years. For global readers, the takeaway is not "China beat Neuralink." It is that the extradural, safety-first design may be the version that actually scales into hospitals — because doctors adopt the implant they can defend to a patient, not the one with the sharpest demo. ## What readers can do now - If you follow medtech investing, watch *registry progress*, not implant count: a 36-patient GCP cohort clearing confirmatory trials is the real signal. - If you work in rehab or neurology, the extradural approach is worth reading up on — it changes which patients are even candidates. - If you build hardware, note the bottleneck is still the electrode-tissue interface, not compute. That is where the next decade of value sits. ## Honest limitations Figures in this article come from the Beijing Institute for Brain Science, affiliated companies, and Chinese state-media reporting (People's Daily, Beijing News) in April 2026; they are not yet backed by large peer-reviewed multi-center efficacy studies. Patient counts (10 implants, 36 planned) are early-stage. Comparisons to U.S. invasive BCIs are directional, not head-to-head. "Semi-invasive" outcomes will vary by implant site and patient condition, and long-term durability beyond one year remains to be established. --- Published by NeuroAI (https://neuroai.site/) — https://neuroai.site/a/na-bci-beinao-10-implants Free to quote with attribution and a link to the original.